students
Chendo Dieleman
BSc
Molecular mechanisms driving resistance to medically important triazoles in Aspergillus fumigatus

Research Questions/Hypotheses

Infections caused by the major mold pathogen of humans, Aspergillus fumigatus, are associated with a concerningly high death toll exceeding several hundred thousand deaths each year. In addition to the severely limited therapeutic options that are currently available, resistance to the major drug class employed clinically, the azoles, is steadily increasing.

Resistance is commonly associated with mutations of the azole drug target encoding gene cyp51A, however a large proportion of isolates are protected against azole treatment by so far unknown mechanisms-of-resistance. The main research question that is going to be investigated in this project focuses on the hypothesis that several further mutations (non-cyp51A) leading to increased or decreased activity of single or multiple genes, create azole resistance.

Approach/Methods

The major objective of this PhD project will be to uncover transcriptional regulation-based defects of a pre-selected set of genes that confer azole antifungal resistance in Aspergillus fumigatus

To achieve this, the project encompasses training and utilization of state-of-the-art and advanced techniques covering the fields of Molecular Biology, Microbiology, Biochemistry and Cellular Biology including nucleic acid manipulation, genetic engineering, phenotyping, drug-susceptibility testing, metabolite analysis and diverse microscopic techniques.

 

Info
Principal Investigator

Assoz. Prof. Mag.biol. Fabio Gsaller PhD

Nationality

Netherlands

why MYCOS ?

TBA
Chendo Dieleman
Chendo Dieleman
BSc

Molecular mechanisms driving resistance to medically important triazoles in Aspergillus fumigatus

Research Questions/Hypotheses

Infections caused by the major mold pathogen of humans, Aspergillus fumigatus, are associated with a concerningly high death toll exceeding several hundred thousand deaths each year. In addition to the severely limited therapeutic options that are currently available, resistance to the major drug class employed clinically, the azoles, is steadily increasing.

Resistance is commonly associated with mutations of the azole drug target encoding gene cyp51A, however a large proportion of isolates are protected against azole treatment by so far unknown mechanisms-of-resistance. The main research question that is going to be investigated in this project focuses on the hypothesis that several further mutations (non-cyp51A) leading to increased or decreased activity of single or multiple genes, create azole resistance.

Approach/Methods

The major objective of this PhD project will be to uncover transcriptional regulation-based defects of a pre-selected set of genes that confer azole antifungal resistance in Aspergillus fumigatus

To achieve this, the project encompasses training and utilization of state-of-the-art and advanced techniques covering the fields of Molecular Biology, Microbiology, Biochemistry and Cellular Biology including nucleic acid manipulation, genetic engineering, phenotyping, drug-susceptibility testing, metabolite analysis and diverse microscopic techniques.

 


why MYCOS ?
TBA

info:
Principal Investigator:

Assoz. Prof. Mag.biol. Fabio Gsaller PhD

Email:
Nationality:
Netherlands


contact

PROGRAM SPEAKER

Univ.-Prof. Dr. Michaela Lackner
Medical University of Innsbruck
Schöpfstrasse 41
A-6020 Innsbruck

Imprint

Partner
 
This project is funded by MUI and UIBK. Dummy Icons © Julia Solerti, büro54 Nutzungsrechte bei der Medizinischen Universität Innsbruck. Portrait pictures: MUI/Bullock.